JPRN-jRCTs032220646已完成Unknown
Effect on Female Pattern Hair Loss by health equipment RAYOCOMP
Miyata Akinobu0 个研究点目标入组 27 人开始时间: 2023年2月17日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
The test product was used continuously for 12 weeks to evaluate the condition of female pattern hair loss patients aged 40 years and older. As a result, compared to the non-intervention group, the test product group showed significant improvement in hair diameter and head condition after 12 weeks. In comparison with before use, significant improvements were seen in the condition of the head after 8 weeks and in the hair diameter and condition of the head after 12 weeks.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 <= 59age old（—）
- 性别
- Female
入选标准
- •1. Female Pattern Hair Loss (FPHL) over 40 years old (including FAGA and alopecia areata)
- •2.Persons whose parietal condition corresponds to I-2 to II-1 on the Savin Female Density scale
- •3. When using the test equipment, test that you do not put or wear electronic products (including smartphones, chargers, music players, earphones, mobile games, etc.) within 1m from your body (including the next room across the wall). Those who can continue during the implementation period
- •4. Those who can promise not to wear metal objects (accessories, buttons, watches, hairpins, etc.) when using the test equipment.
- •5. Those who can promise not to wear chemical fiber clothing (polyester, nylon, vinyl, fleece, etc.) when using the test equipment (bedding such as 100% cotton or silk pajamas is acceptable)
- •6.Subjects who can use 100% cotton or linen sheets at bedtime during the test period.
- •7.Subjects who fully understood the participation in this research and gave written informed consent of their own free will.
排除标准
- •1.Subjects with symptoms of atopic dermatitis
- •2. Those who are receiving treatment, medication, or lifestyle guidance from a doctor
- •3. Severe cerebrovascular disease, heart disease, liver disease, renal disease, digestive system disease, infectious disease requiring notification, etc. suffering from
- •4. Those who use a pacemaker or defibrillator
- •5. Excessive smokers*1 and regular alcohol users*2
- •6.Subjects with significant abnormalities in blood pressure measurement and blood tests
- •7. Those who are pregnant or breast-feeding, or those planning to do so (including those who have just given birth)
- •8.Subjects who are receiving hormone replacement therapy
- •9.Subjects who plan to start new hair care (hair restorer, thinning hair treatment, hair beauty treatment, etc.) during the test period, or those who have started within the last 2 months
- •10. Subjects who have experience of aesthetic medicine on the test site, and who have hair thickening
- •11.Subjects who plan to change their lifestyle habits during the test period
- •12.Subjects who have participated in, or plan to participate in, other clinical trials that are affected by this study within one month prior to obtaining informed consent
- •13.In addition, those who are judged to be inappropriate by the principal investigator
研究者
相似试验
撤回
不适用
Hair Up Prospective StudyHair LossNCT03652701Shmuel Gonen Technologies Ltd.
已完成
1 期
A study to evaluate the efficacy of test product in hair fall benefitsCTRI/2020/03/023682Diabliss Consumer Products Pvt Ltd36
已完成
2 期
Study of effectiveness and safety on the hair loss restraint by scalp cooling with scalp cooling device in the breast cancer chemotherapyBreast cancerJPRN-UMIN000031534ational Hospital Organization Kyushu Cancer Center120
暂停
2 期
Hair loss restraint by scalp cooling enforcementBreast cancerJPRN-jRCTs072180051TOKUNAGA Eriko21
已完成
不适用
Treatment of Androgenic Alopecia in MalesHair LossMale Pattern BaldnessAndrogenetic AlopeciaNCT00947219Lexington International, LLC79